Company Filing History:
Years Active: 2017-2023
Title: Steven Hecht: Innovator in Cellular Assays
Introduction
Steven Hecht is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of cellular assays, holding a total of 4 patents. His work focuses on improving diagnostic processes, particularly in the context of cervical health.
Latest Patents
One of Steven's latest patents is a method of partial lysis and assay. This innovative method describes a process of treating a sample comprising cells through partial lysing. Cells are subjected to a technique such as bead beating, which lyses some cells in the mixture. The resultant sample mixture is suitable for both cell morphology screening and genetic screening. A first portion of the partially lysed sample can be mounted on a slide for observation of atypical cells and cytologic abnormalities. A second portion can be screened for genetic markers associated with cervical cancer risk. This method is particularly beneficial for cervical screening, as it combines cytology and genetic screening to provide a comprehensive view of cervical health. The disclosed method streamlines the diagnostic process for protocols requiring both types of assays without compromising screening accuracy.
Career Highlights
Steven Hecht is currently employed at Hologic, Inc., where he continues to develop innovative solutions in the field of medical diagnostics. His work has been instrumental in advancing methodologies that enhance the accuracy and efficiency of cellular assays.
Collaborations
Steven collaborates with talented individuals such as Erin Coffman and Paul MacLean, contributing to a dynamic team focused on innovation in healthcare technology.
Conclusion
Steven Hecht's contributions to the field of cellular assays exemplify the impact of innovation in medical diagnostics. His work not only advances scientific understanding but also improves patient care through enhanced screening methods.